Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03095612 |
| Title | Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Texas Southwestern Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
| University of Pittsburgh Medical Center-Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| University of Vanderbilt Medical Center-Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75063 | United States | Details | |
| University of Washington-Seattle Cancer Care Alliance | Seattle | Washington | 98195 | United States | Details |